FDA clears Cordis' high-pressure balloon catheter:
This article was originally published in Clinica
Executive Summary
The US FDA has cleared Cordis Endovascular's Powerflex high-pressure balloon catheter for treating blockages in native or synthetic vascular access grafts and in peripheral vessels, such as the renal, iliac and femoral arteries. The device combines an extremely low profile for minimal invasiveness with a strength and durability tough enough to treat calcified lesions, said the Warren, New Jersey-based company.